Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease

Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease

Agomelatine is a selective agonist of melatonin receptor 1A/melatonin receptor 1B (MT1/MT2) and antagonist of 5-hydroxytryptamine 2C receptors. It is used clinically to treat major depressive episodes in adults. The pro-chronobiological activity of agomelatine reconstructs sleep-wake rhythms and nor...

Full description

Bibliographic Details
Main Authors: Qiang Su, Tian Li, Guo-Wei Liu, Yan-Li Zhang, Jun-Hong Guo, Zhao-Jun Wang, Mei-Na Wu, Jin-Shun Qi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Neural Regeneration Research
Subjects:
agomelatine; antidepressant; anxiety; apathy; circadian-rhythm sleep disorder; cognitive impairment; depression; melatonergic; memory disorder; mood disorder; neurodegenerative disease
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=4;spage=727;epage=733;aulast=Su

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=4;spage=727;epage=733;aulast=Su

Similar Items